Table 3 Comparison of clinical and economic outcomes in overall cohort
From: Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
Outcome | Conventional treatment + salvianolate injection (n = 401) | Conventional treatment (n = 401) | Difference | P |
|---|---|---|---|---|
Hospital stay (days) | 11.7 (± 7.5) | 14.6 (± 11.5) | − 2.9 | < 0.05 |
Total nitrates dosage (mg) | 457.7 (± 511.4) | 630.1 (± 650.4) | − 172.4 | < 0.05 |
Total medical costs (CNY) | 14,726.3 (± 18,165.8) | 17,362.7 (± 22,161.8) | − 2636.4 | 0.054 |
Subcategories costs (CNY) | ||||
 Supplies cost | 5538.6 (± 13,486.6) | 5770.9 (12,458.5) | − 232.3 | 0.801 |
 Pharmacy cost | 3122.5 (± 3124.2) | 4890.1 (± 5218.0) | − 1767.6 | < 0.05 |
 Examination cost | 1410.6 (± 1277.5) | 1954.9 (± 2427.2) | − 544.3 | < 0.05 |
 Laboratory cost | 1351.7 (± 818.3) | 1564.2 (± 1330.3) | − 212.5 | < 0.05 |
 Operation cost | 2626.2 (± 1884.2) | 4223.2 (± 3211.2) | − 1597.0 | < 0.05 |
 Treatment cost | 447.4 (± 831.6) | 1005.7 (± 1687.1) | − 558.3 | < 0.05 |
 Chinese patent drug cost | 1316.6 (± 581.0) | 141.7 (± 474.6) | 1174.9 | < 0.05 |